PharMerica (PMC) Tops Q2 EPS by 4c; Boosts FY14 Outlook

PharMerica (NYSE: PMC) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $448.6 million versus the consensus estimate of $432.7 million.

PharMerica sees FY2014 EPS of $1.47-$1.52, versus prior guidance of $1.4-$1.5 and the consensus of $1.49. PharMerica sees FY2014 revenue of $1.73-1.78 billion, versus prior guidance of $1.70-1.75 billion and the consensus of $1.75 billion.

For earnings history and earnings-related data on PharMerica (PMC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping drops bid for Genco after price demands spike to $36.91
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c